Rhoen Klinikum (RHK) PT Set at €22.00 by Cfra

Cfra set a €22.00 ($25.58) price objective on Rhoen Klinikum (ETR:RHK) in a research note published on Monday morning. The firm currently has a sell rating on the stock.

Other equities research analysts also recently issued reports about the stock. Commerzbank set a €25.00 ($29.07) price objective on shares of Rhoen Klinikum and gave the stock a neutral rating in a research note on Thursday, August 2nd. Berenberg Bank set a €27.75 ($32.27) price objective on shares of Rhoen Klinikum and gave the stock a neutral rating in a research note on Monday, August 6th. Independent Research set a €26.00 ($30.23) price objective on shares of Rhoen Klinikum and gave the stock a neutral rating in a research note on Wednesday, August 8th. Credit Suisse Group set a €19.00 ($22.09) target price on shares of Rhoen Klinikum and gave the company a sell rating in a research report on Monday, August 6th. Finally, Kepler Capital Markets set a €22.00 ($25.58) target price on shares of Rhoen Klinikum and gave the company a sell rating in a research report on Thursday, August 2nd. Four research analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. The stock currently has an average rating of Hold and a consensus price target of €22.84 ($26.56).

ETR:RHK opened at €22.12 ($25.72) on Monday. Rhoen Klinikum has a 12 month low of €25.08 ($29.16) and a 12 month high of €32.12 ($37.35).



Rhoen Klinikum Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Read More: Capital Gains

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply